« Back to Medicines list

Circadin 2mg prolonged-release tablets

  • Name:

    Circadin 2mg prolonged-release tablets

  • Company:
    info
  • Active Ingredients:

    melatonin

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Summary of Product Characteristics last updated on medicines.ie: 4/6/2020

Click on this link to Download PDF directly

Flynn Pharma Ltd

Flynn Pharma Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name Cefuroxime 1.5 Powder for Injection Active Ingredients Cefuroxime Sodium
Medicine Name Cefuroxime 750mg Powder for Injection Active Ingredients Cefuroxime Sodium
Medicine Name Circadin 2mg prolonged-release tablets Active Ingredients melatonin
Medicine Name Distaclor 125mg/5ml Granules for Oral Suspension Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor 250mg Granules for Oral Suspension Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor LA Forte 500mg Tablet Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor LA Tablets 375mg Active Ingredients Cefaclor monohydrate
Medicine Name Distaclor Suspension Active Ingredients Cefaclor
Medicine Name Keflex 125mg/5ml Powder for Oral Suspension Active Ingredients Cefalexin
Medicine Name Keflex 250mg Hard Capsules Active Ingredients Cefalexin monohydrate
Medicine Name Keflex 250mg Powder for Oral Suspension Active Ingredients Cefalexin
Medicine Name Keflex 500mg Film Coated Tablets Active Ingredients Cefalexin monohydrate
Medicine Name Medikinet MR modified-release capsules, hard Active Ingredients Methylphenidate Hydrochloride
Medicine Name Medikinet Tablets Active Ingredients Methylphenidate Hydrochloride
Medicine Name Vancocin 1g Powder for Oral Solution Active Ingredients Vancomycin Hydrochloride
Medicine Name Vancocin Matrigel 125mg Hard Capsules Active Ingredients Vancomycin Hydrochloride
Medicine Name Vancomycin 500mg Powder for oral solution Active Ingredients Vancomycin Hydrochloride
1 - 0 of 17 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 4 June 2020 SPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic properties

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

updates to section 4.2 and 5.1

Updated on 4 June 2020 SPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic properties

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 28 August 2019 SPC

Reasons for updating

  • File format updated to PDF

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 7 June 2018 SPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Update in the MA holder address

Updated on 9 August 2016 SPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)